Healx
Generated by Meeveem AI
"AI powered drug discovery accelerating treatments for rare diseases"
Cambridge
•51 - 250 Employees
•Healthcare Analytics
About Healx
Healx combines artificial intelligence with pharmacological expertise to accelerate treatments for rare diseases. Traditional drug development has a 5% success rate, leaving 90% of rare diseases without therapies. By analysing drug and disease data, Healx identifies connections between existing compounds and rare conditions, enabling faster, cost effective pathways to new treatments. The company operates multiple programmes in parallel, advancing therapies from prediction to patient. Its approach de-risks discovery by repurposing known compounds. This patient inspired model brings hope to 300 million people living with rare diseases, partnering with patient groups, pharmaceutical companies and research institutions.
Illustrative visual - may not reflect the actual offering.
Illustrative visual - may not reflect the actual offering.
66
Team Members
2014
Founded
Series C
Funding
Hybrid
Work Environment
Our Vision
A world where every rare disease patient has access to effective treatment, where AI and human expertise combine to unlock cures at unprecedented speed and scale, transforming millions of lives.
Our Mission
At Healx, our mission is to achieve unprecedented rare disease impact by pioneering the next generation of drug discovery.